You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

palbociclib

Showing 51 - 75 of 184
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Australia (OP-1250, Palbociclib)

Recruiting
  • Breast Cancer
  • Westmead, New South Wales, Australia
  • +4 more
Feb 23, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Palbociclib
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Lung Cancer Trial in Boston (Binimetinib, Palbociclib)

Recruiting
  • Lung Cancer
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Breast Cancer Stage IV, Radiotherapy, Surgery Trial in France (Palbociclib, locoregional treatment)

Recruiting
  • Breast Cancer Stage IV
  • +2 more
  • Palbociclib
  • locoregional treatment
  • Angers, France
  • +25 more
Sep 1, 2022

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

Completed
  • Neoadjuvant Operable Breast Cancer
  • Paris, France
  • +1 more
Mar 14, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)

Recruiting
  • Metastatic Malignant Neoplasm to Brain
  • Palbociclib
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
  • +1 more
Jan 25, 2022

Prostate Cancer Trial in Canada (Palbociclib)

Active, not recruiting
  • Prostate Cancer
  • Palbociclib
  • Halifax, Nova Scotia, Canada
  • +6 more
Jan 28, 2022

Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)

Terminated
  • Breast Neoplasm
  • Palbociclib
  • +4 more
  • Mainz, Germany
    University Hospital Mainz
Dec 16, 2021

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Palbociclib
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Sep 29, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

Completed
Has Results
  • Breast Cancer
  • Palbociclib
  • Aromatase Inhibitor
  • San Francisco, California
  • +9 more
Mar 18, 2022

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • Palbociclib
  • +2 more
  • San Francisco, California
  • +8 more
Feb 16, 2022

18F-FES-PET/CT Parameters on Palbociclib Combined With ET

Active, not recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 13, 2021

Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

Recruiting
  • Cancer
  • +12 more
  • Palbociclib
  • +2 more
  • Tripoli, North Lebanon, Lebanon
  • +1 more
Oct 5, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Soft-tissue Sarcoma, Osteosarcoma, Chordoma Trial in Spain (Palbociclib)

Recruiting
  • Soft-tissue Sarcoma
  • +2 more
  • Palbociclib
  • Barcelona, Spain
  • +18 more
May 30, 2022

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • +2 more
  • Miami, Florida
  • +21 more
Mar 18, 2022

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Metastatic Breast Cancer Trial in Spain (Palbociclib, Trastuzumab, Endocrine therapy)

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • +4 more
  • Badalona, Barcelona, Spain
  • +34 more
Oct 24, 2022

Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • +2 more
  • Palbociclib
  • +3 more
  • Stanford, California
    Lucile Packard Children's Hospital Stanford
Sep 20, 2021